A Novel EGFR Targeted Immunotoxin Based on Cetuximab and Type 1 RIP Quinoin Overcomes the Cetuximab Resistance in Colorectal Cancer Cells

Nicola Landi(University of Campania "Luigi Vanvitelli"), Antimo Di Maro(University of Campania "Luigi Vanvitelli")

Toxins

January 9, 2023

10.3390/toxins15010057

Cited by 6

Related Papers

Identification of Novel Cryptic Multifunctional Antimicrobial Peptides from the Human Stomach Enabled by a Computational–Experimental Platform

|ACS Synthetic Biology|2018|78